No spike in schizophrenia, other diagnoses among people with dementia after feds crack down on antipsychotic...
By
Kimberly Marselas
Aug 28, 2024
Federal policies designed to reduce use of antipsychotic medications in nursing homes did not lead to clinically significantly higher rates of schizophrenia diagnoses among people living with dementia,...
Alzheimer’s prognosis models should expand data sources
By
Kristen Fischer
Aug 12, 2024
Integrating data from nursing home electronic health records (EHRs) and claims in addition to the minimum data set (MDS) — data required for nursing home residents — could be better than just relying...
Researcher eyes assisted living as base for testing AI-powered dementia screening technology
By
Kimberly Bonvissuto
Aug 14, 2024
A research-based startup is looking to assisted living providers as it works to commercialize its artificial intelligence-powered platform to improve the dementia screening process.
CDC releases new profile of assisted living residents
By
Kimberly Bonvissuto
Aug 09, 2024
Residents living in assisted living and other residential care communities in 2022 mostly were female (67%), white (92%) and 85 or older (53%), according to a new report from the Centers for Disease Control...
What happens if biomarker tests spot Alzheimer’s before people show symptoms?
By
Kristen Fischer
Aug 05, 2024
As of now, no therapy is approved by the Food and Drug Administration for people at risk of Alzheimer’s disease who don’t have symptoms. But blood tests that can spot biomarkers linked to the disease...
Digital cognitive impairment assessment tool earns validation
By
Donna Shryer
Aug 06, 2024
New research presented at the Alzheimer’s Association International Conference (AAIC) provided validation for BrainCheck, a digital cognitive assessment tool. Researchers from the University of Washington...
Alzheimer’s care, quality of life improve with innovative immersion room
By
Jessica R. Towhey
Aug 05, 2024
A creative new room at a Long Island, NY, nursing home may serve as a model for improving the quality of Alzheimer’s care.
Amyloid probability score 2 has high diagnostic accuracy for Alzheimer’s disease
Jul 31, 2024
The diagnostic accuracy 73% for dementia specialists compared with 91% using the APS2.